Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Kairos Pharma, Ltd./ ARS

SEC Filing · ARS

Kairos Pharma, Ltd.

KAPANYSE_AMERICANEQUITYCurrent

SEC Filing

Filed May 22, 2026Accepted May 22, 2026, 4:12 PM EDTCIK 1962011Accession 0001493152-26-025021
View company →Permanent SEC source ↗
Share

Company context

Current securities

KAPANYSE_AMERICAN · EQUITY · Current

Recent company filings

  1. Regulation FD DisclosureSep 14, 2026
  2. Material Modification to Rights of Security Holders · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD DisclosureAug 21, 2026
  3. 10-Q filingAug 12, 2026
  4. Entry into a Material Definitive Agreement · Other EventsJul 22, 2026
  5. Other EventsJul 15, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗